Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin XR for pre-diabetes after stroke
ACTRN12617001168347Phase 4Not yet recruiting
- Sponsor
- Austin Health
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in prediabetes (2 arms), sponsored by Austin Health. Primary endpoint: Safety and tolerability of metformin XR. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on ACTRN12617001168347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001168347.